1. Introduction {#sec1-molecules-21-00057}
===============

Nitric oxide is a by-product of combustion of the substances in the air, and it is abundant in automobile engines. Because of the large vehicle population, significant amounts of NO~x~ are emitted to the atmosphere. Attention is given to the catalyst system which simultaneously promotes the reduction of NO. Most reports show that NO can be broke into N~2~ and O~2~ by nano-TiO~2~ as a catalyst with the help of UV light and sensible light \[[@B1-molecules-21-00057],[@B2-molecules-21-00057]\]. In mammals including humans, NO is also an important cellular signaling molecule involved in many physiological and pathological processes. NO, known as an endothelium-derived relaxing factor (EDRF), is a powerful vasodilator with a short half-life of a few seconds in the blood. The endothelium of blood vessels uses NO to signal the surrounding smooth muscle to relax, thus resulting in vasodilation \[[@B3-molecules-21-00057],[@B4-molecules-21-00057],[@B5-molecules-21-00057]\]. Recent studies have shown that NO is also essential for host innate immune responses to pathogens such as viruses, bacteria, fungi, and parasites, which is mainly generated by macrophages \[[@B6-molecules-21-00057],[@B7-molecules-21-00057],[@B8-molecules-21-00057],[@B9-molecules-21-00057]\]. However, excessive production of NO is a common feature of most diseases associated with infection and acute or chronic inflammation, which contributes to edema formation and pain sensitization \[[@B10-molecules-21-00057],[@B11-molecules-21-00057]\].

In the present study, we examined whether nano-TiO~2~ might act as a deswelling material. To gain insights into the molecular mechanism, we further investigated the effects of nano-TiO~2~ on degrading NO and inhibiting vascular permeability. We believe that further study on nano-TiO~2~ will aid in our ability to design effective interventions and treatments for edema involved diseases.

2. Results and Discussion {#sec2-molecules-21-00057}
=========================

2.1. Effects of Nano-TiO~2~ on LPS-Induced NO Production {#sec2dot1-molecules-21-00057}
--------------------------------------------------------

Nano-TiO~2~ is demonstrated to be active on NO absorption in the air. In mammals including humans, NO is mainly generated by phagocytes (monocytes, macrophages, and neutrophils). Here, we used RAW264.7 mouse macrophages to investigate the effects of nano-TiO~2~ on LPS-induced NO production *in vitro*.

We first measured the cytotoxicity of nano-materials in RAW264.7 cells by using the MTT assay. RAW264.7 cells were cultured with LPS (100 ng/mL) in the presence or absence of nano-materials. As shown in [Figure 1](#molecules-21-00057-f001){ref-type="fig"}A, nano-ZnO, nano-SnO and nano-TiO~2~ at the concentrations of 50, 100 and 150 μM had no cytotoxic effect.

![Effects of nano-TiO~2~ on cell viability and nitric oxide (NO) production in LPS-induced RAW 264.7 mouse macrophages. After 24 h treatment, cell viability (**A**) was evaluated by MTT assay and NO production (**B**) was measured by the Griess reaction. Normal group was treated with media only. Control group was treated with LPS (100 ng/mL) alone. Data were shown as means ± standard deviation (SD) of three independent experiments. \*\* *p* \< 0.01 against control group; (**C**) The expression of iNOS was dectected by Western blot.](molecules-21-00057-g001){#molecules-21-00057-f001}

NO is a relatively unstable molecule, which is produced at low concentrations and rapidly converted into nitrate within 10 s of its formation \[[@B12-molecules-21-00057]\]. Thus, the concentration of nitrate is commonly used to reflect the levels of NO production. Following 24 h of LPS stimulation, a higher level of NO production were measured in the culture media of RAW264.7 cells treated with LPS alone when compared to the untreated cells. However, the significant induction of NO production was reduced by nano-TiO~2~ in a dose-dependent manner, whereas other nano-materials did not reduce the nitrate levels ([Figure 1](#molecules-21-00057-f001){ref-type="fig"}B). We further demonstrated that the expression of iNOS in macrophages decreased after treated with nano-TiO~2~ at the concentration of 50, 100 and 150 μM. Thus, nano-TiO~2~ might be a candidate material for relieving vasodilation concerned with excessive NO production.

Moreover, we analyzed the nano-size of the nano-TiO~2~ used in this study, and separated it into anatase and rutile type ([Figure 2](#molecules-21-00057-f002){ref-type="fig"}). Then, we detected the effect of nano-TiO~2~ in different types on NO degradation. Both anatase and rutile nano-TiO~2~ presented NO degradation action with no significant differences ([Figure 2](#molecules-21-00057-f002){ref-type="fig"}C). Thus, we chose the anatase nano-TiO~2~ for the further study.

![Analysis of nano-TiO~2~. (**A**) Nano-TiO~2~ was measured by electron microscope to a diameter of 21 nm; (**B**) Nano-TiO~2~ was analyzed by XRD method, and separated into anatase and rutile type; (**C**) Anatase and rutile nano-TiO~2~ presented NO degradation action with no significant differences. Data were shown as means ± SD of three independent experiments.](molecules-21-00057-g002){#molecules-21-00057-f002}

2.2. Effects of Nano-TiO~2~ on Inhibiting Vascular Permeability {#sec2dot2-molecules-21-00057}
---------------------------------------------------------------

In 1980, Furchgott and Zawadsko reported the crucial role endothelium in the relaxation of arterial smooth muscle by acetylcholine. The report was based on the integrity of endothelial cells and suggested that the endothelial cells might generate a special transfer molecule causing vascular smooth muscle cell (VSMC) relaxation. Thus, they named this molecule as endothelium-derived relaxing factor (EDRF) \[[@B3-molecules-21-00057],[@B4-molecules-21-00057]\]. Later in 1986, Furchgott and Ignarro further proved that NO is the specific transfer molecule that played the role of EDRF by using spectral analysis of hemoglobin \[[@B5-molecules-21-00057]\]. It is now known that NO can induce the synthesis of cyclic guanosine monophosophate (cGMP) through guanylyl cyclase (GC) leading to relaxation of myosin \[[@B13-molecules-21-00057],[@B14-molecules-21-00057],[@B15-molecules-21-00057],[@B16-molecules-21-00057]\]. Thus, we wondered if nano-TiO~2~ might present an inhibitory effect on vascular permeability via degradation of NO *in vivo*.

We first investigated the inhibitory effect of nano-TiO~2~ on vascular permeability in female SD rats. The rats were subcutaneous injected with 50 μM, 100 μM and 150 μM nano-TiO~2~ for 1 h prior to the addition of LPS stimulation. NO production decreased significantly in the nano-TiO~2~ treated group ([Figure 3](#molecules-21-00057-f003){ref-type="fig"}A). Evans blue extravasation was employed to evaluate the vascular permeability \[[@B17-molecules-21-00057]\]. As shown in [Figure 3](#molecules-21-00057-f003){ref-type="fig"}B, Evans blue extravasation was significantly decreased in the nano-TiO~2~ treated groups in a dose dependent manner when compared to the rats stimulated with LPS alone (*p* \< 0.01).

![Effects of nano-TiO~2~ on inhibiting vascular permeability. SD rats were injected with 50, 100, and 150 μM nano-TiO~2~ for 1 h prior to the addition of LPS stimulation, compared to 100 μM L-NAME. (**A**) NO~2~^−^ in the skin was detected using the Griess method; (**B**) Evans blue extravasation was used to evaluate the vascular permeability. Data were shown as means ± SD of three independent experiments. \*\* *p* \< 0.01 against control group.](molecules-21-00057-g003){#molecules-21-00057-f003}

Nano-TiO~2~ is a white pigment widely used in foods, sunscreens, and cosmetic products \[[@B18-molecules-21-00057],[@B19-molecules-21-00057],[@B20-molecules-21-00057],[@B21-molecules-21-00057]\]. Here, we prepared ointments which contained 5.0%, 10.0% and 15.0% of nano-TiO~2~ with vaseline and lanolin in the ratio of 1:2 as an accessory. Three points were marked on the median line of the depilated dorsal skin, where 2 mg of the nano-TiO~2~ ointment was rubbed carefully for 1 min on a circular area with a 2 cm diameter with each point. The nano-TiO~2~ ointment was applied 1 h before LPS subcutaneous injection. NO production decreased significantly in the nano-TiO~2~ treated group ([Figure 4](#molecules-21-00057-f004){ref-type="fig"}A). More importantly, the vascular permeability was significantly inhibited by nano-TiO~2~ ointment in a dose dependent manner when compared to the rats treated with accessories ([Figure 4](#molecules-21-00057-f004){ref-type="fig"}B).

![Effects of nano-TiO~2~ ointment on inhibiting vascular permeability. Ointment contained 5.0%, 10.0%, and 15.0% of nano-TiO~2~ were rubbed on the depilated dorsal skin of rats. (**A**) NO~2~^−^ in the skin was detected using the Griess method; (**B**) Evans blue dye extracted from the skin was measured. Data were shown as means ± SD of three independent experiments. \*\* *p* \< 0.01 against control group.](molecules-21-00057-g004){#molecules-21-00057-f004}

2.3. Effects of Nano-TiO~2~ on Carrageenan-Induced Paw Edema {#sec2dot3-molecules-21-00057}
------------------------------------------------------------

An increase in vessel wall permeability contributes to the formation of edemas. Here, we used the carrageenan-induced paw edema model to evaluate the deswelling effect of nano-TiO~2~ \[[@B22-molecules-21-00057],[@B23-molecules-21-00057],[@B24-molecules-21-00057]\].

In this study, SD rats were divided into five groups (eight animals in each group), and 0.1 mL of nano-TiO~2~ was administered 1 h before carrageenan stimulation. NO production decreased significantly in the footpad of nano-TiO~2~ treated rats ([Figure 5](#molecules-21-00057-f005){ref-type="fig"}A). In addition, subcutaneous injection of nano-TiO~2~ resulted in a significant reduction in rat paw edema. The deswelling effect of nano-TiO~2~ at doses of 50--150 μM was statistically significant for reducing paw edema of rats at 2, 4, 6, 8 and 10 h after induction of edema ([Figure 5](#molecules-21-00057-f005){ref-type="fig"}B).

![Effect of nano-TiO~2~ on carrageenan-induced paw edema. 0.1 mL of nano-TiO~2~ (50--100 μM) was administered 1 h before carrageenan stimulation. (**A**) NO~2~^−^ in the footpad was detected using the Griess method; (**B**) The degree of swelling in the footpads was measured using a plethysmometer. Data were shown as means ± SD of three independent experiments. \* *p* \< 0.05 against control group; \*\* *p* \< 0.01 against control group.](molecules-21-00057-g005){#molecules-21-00057-f005}

Then, we evaluate the inhibitory effect of nano-TiO~2~ ointment on carrageenan-induced paw edema. The volumes of the unilateral hind paws of these animals were measured, and on each paw, nano-TiO~2~ ointment was carefully rubbed 1 h before the carrageenan was given. This ointment-treated part was covered softly with a fiber cloth in order to prevent the rats from licking off the ointment. Then, carrageenan was injected subcutaneously into the paw, and the volume of the hind paw was measured at 2, 4, 6, 8, and 10 h. Ointment with 10% nano-TiO~2~ showed a significant reduction of NO release and rat paw edema ([Figure 6](#molecules-21-00057-f006){ref-type="fig"}). Carrageenan-induced edema develops through mediators in three phases. The early phase is caused by histamine release, the second phase is mediated by kinin, and the late phase is caused by prostaglandins. According to the NO degradation effects of nano-TiO~2~, we proposed that nano-TiO~2~ are effective for the first phase of edema formation.

![Effect of nano-TiO~2~ ointment on carrageenan-induced paw edema. Ointment contained 10.0% of nano-TiO~2~ was smeared on the SD rats' right footpads 1 h prior to the addition of carrageenan induction. (**A**) NO~2~^−^ in the footpad was detected using the Griess method; (**B**) The degree of swelling in the footpads was measured using a plethysmometer; (**C**) The degree of swelling in the foot pads was photographed. Data were shown as means ± SD of three independent experiments. \* *p* \< 0.05 against control group; \*\* *p* \< 0.01 against control group.](molecules-21-00057-g006){#molecules-21-00057-f006}

Moreover, the application of the ointment with 15% nano-TiO~2~ to the skin of the rats for 1 month had no irritation on the animal skin ([Figure 7](#molecules-21-00057-f007){ref-type="fig"}). It is reported that nano TiO~2~ does not appear to significantly penetrate the intact skin \[[@B25-molecules-21-00057]\]. However, the compromised skin allows nano-sized particle penetration through the skin \[[@B26-molecules-21-00057]\]. Therefore, we believe that the nano-TiO~2~ ointment is available for the prevention and treatment of edema formation in the skin wounds.

![Irritation of nano-TiO~2~ ointment on the skin of rats. Accessory (**A**) and ointment with 15% nano-TiO~2~ (**B**) was rubbed on the skin of rats for month.](molecules-21-00057-g007){#molecules-21-00057-f007}

3. Experimental Section {#sec3-molecules-21-00057}
=======================

3.1. Animals {#sec3dot1-molecules-21-00057}
------------

All experiments was performed in compliance with relevant laws and institutional guidelines and approved by the Peking University Biomedical Ethics Committee. Female SD rats (4--6 weeks old) were provided by Beijing Laboratory Animal Research Center. The experimental animals were housed separately at room temperature (20 ± 2 °C), humidity 55%--60%.

3.2. Cell Culture {#sec3dot2-molecules-21-00057}
-----------------

RAW264.7 mouse macrophages were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA) and cultured in Dulbecco's modified Eagle's medium (DMEM, Gobico, NY, USA) supplemented with 100 µg/mL of penicillin/streptomycin and 10% heat-inactivated fetal bovine serum (FBS, Gibco, NY, USA), in a humidified atmosphere of 5% CO~2~ at 37 °C, until reaching 80% confluency \[[@B27-molecules-21-00057]\]. The medium was changed every 3 days.

3.3. Nano Materials {#sec3dot3-molecules-21-00057}
-------------------

Nano-TiO~2~, nano-ZnO and nano-SnO were purchased from Shanghai Huijing Sub-Nanoseale New Material Co., Ltd. (Shanghai, China). To prepare nano TiO~2~ ointment, we mixed vaseline and lanolin in the ratio of 1:2 as an accessory and then mixed with nano-TiO~2~ in different proportions.

3.4. Griess Method {#sec3dot4-molecules-21-00057}
------------------

We used a total Nitrate/Nitrite Parameter Assay Kit for determining NO according to the instructions (Catalog KGE001, R & D, Minneapolis, MN, USA) \[[@B28-molecules-21-00057]\]. The completed reaction was read at 540 nm. The concentrations of NO~2~^−^ in the cell culture supernatant were expressed as NO~2~^−^ (µM). In addition, the concentration of NO~2~^−^ in the skin or the footpad of rats were calculated as NO~2~^−^ divided by the weight of tissue (nM/mg).

3.5. Western Blot Analysis {#sec3dot5-molecules-21-00057}
--------------------------

Total protein of RAW-264.7 cells were extracted and quantified respectively. After SDS-PAGE, the protein was transferred to polyvinylidene fluoride membrane. The membrane was incubated with antibodies against iNOS and β-actin (Sigma-Aldrich, Saint Louis, MO, USA) overnight at 4 °C. Then the membrane was incubated with the secondary antibodies and detected with enhanced chemiluminescence kit.

3.6. Vascular Permeability Assay {#sec3dot6-molecules-21-00057}
--------------------------------

Evans blue dye at a concentration of 2% (40 mg/kg; Sigma-Aldrich) was injected into the great saphenous vein of 4- to 6-week-old mice. After 60 min, 2 cm-diameter free back skin graft was removed, blotted dry, and weighed. The Evans blue dye was extracted from the skin with 1 mL of formamide overnight at 55 °C and measured spectrophotometrically at 630 nm \[[@B17-molecules-21-00057]\].

3.7. Carrageenan-Induced Paw Edema Method {#sec3dot7-molecules-21-00057}
-----------------------------------------

The deswelling effect of nano-TiO~2~ were evaluated by the carrageenan-induced paw edema method \[[@B22-molecules-21-00057]\]. Nano-TiO~2~ was administered 1 h before the rats received 0.1 mL of carrageenan (1%, *w*/*v*) into the subplantar area of the right hind paw. The control group was treated with the vehicle only. The paw volume of rats was measured before injecting carrageenan and at 2, 4, 6, 8, 10 h after carrageenan stimulation using a plethysmometer (MK-101P, Tokyo, Japan). The edema was expressed as the increase in paw volume, and the percentage of inhibition of edema was expressed as the reduction in volume with respect to the control group \[[@B24-molecules-21-00057]\].

3.8. Statistical Analysis {#sec3dot8-molecules-21-00057}
-------------------------

Data are expressed as means ± SD of three replicate determinations and were analyzed by SPSS (SPSS Inc., Chicago, IL, USA) \[[@B29-molecules-21-00057]\]. Statistical significance was determined by one way Analysis of Variance (ANOVA). Data were regarded as statistically significant when *p* \< 0.01.

4. Conclusions {#sec4-molecules-21-00057}
==============

At the onset of an infection, macrophages undergo activation and release NO responsible for vasodilation. Increased permeability of the blood vessels results in an exudation of plasma proteins and fluid into the tissue, which manifests itself as swelling. During the edema formation process, nano-TiO~2~ plays an important role in reducing NO generated by phagocytes *in vivo*, so as to inhibit vascular permeability, and reduce swelling. In addition, we further prepared nano-TiO~2~ ointment, and proved it to be effective on deswelling. These results suggest that nano-TiO~2~ might act as an deswelling material through reducing NO, which will aid in our ability to design effective interventions and treatments for edema involved diseases.
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